Skip to main content

Table 3 Immunophenotyping of spleen (median/IQR)

From: Tumor growth activity of duloxetine in Ehrlich carcinoma in mice

 

D5

D30

S

p

CD3 (× 107/mL)a

1.0 (0.7–1.4)*

1.3 (1.1–1.6)*

2.2 (1.2–2.4)

0.045

CD4 (× 107/mL)a

0.7 (0.5–0.9)

0.8 (0.6–0.9)

1.5 (1.0–1.7)

0.2448

CD8 (× 107/mL)a

0.2 (0.1–0.2)

0.3 (0.2–0.5)

0.4 (0.2–0.5)

0.088

CD28 (× 105/mL)b

39 (37–40)*

42 (39–45)*

51 (45–52)

0.010

  1. D5 5 mg/kg, D30 duloxetine 30 mg/kg, S saline
  2. aAbsolute frequency of spleen lymphocytes
  3. bFluorescence intensity of spleen lymphocytes; Kruskal–Wallis test; IQR interquartile
  4. *Significant
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us